Recent News

• 03.13.2025 - The Allogene Therapeutics Fourth Quarter 2024 Conference Call
• 03.11.2025 - The Allogene Therapeutics Fourth Quarter 2024 Conference Call
• 03.07.2025 - SCHEDULE 13G/A – Description
• 03.05.2025 - Statement of changes in beneficial ownership of securities
• 03.05.2025 - TD Cowen 45th Annual Health Care Conference
• 03.05.2025 - Initial filing by director officer or owner of more than ten percent
• 03.03.2025 - Allogene Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update
• 03.03.2025 - Allogene Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update
• 03.03.2025 - Allogene Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update
• 02.26.2025 - Allogene Therapeutics Announces Participation in March Investor Conference

Recent Filings

• 03.07.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 03.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.04.2025 - 3 Initial statement of beneficial ownership of securities